Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China
Nan Chen; Jiaqi Qian; Jianghua Chen; Xueqing Yu; Changlin Mei; Chuanming Hao; Gengru Jiang; Hongli Lin; Xinzhou Zhang; Li Zuo; Qiang He; Ping Fu; Xuemei Li; Dalvin Ni; Stefan Hemmerich; Cameron Liu; Lynda Szczech; Anatole Besarab; Thomas B. Neff; Kin-Hung Peony Yu; Frank H. Valone
Author Information: Institute of Nephrology, Department of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.